Top Markets
Coin of the day
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Rang in Aktien #100
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations... Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Aktienkurs
$150.78
Zuletzt synchronisiert: 2026-09-18
Marktkapitalisierung
$187.20B
Veränderung (1 Tag)
-0.08%
Veränderung (1 Jahr)
32.15%
Land
US
Handel Gilead Sciences, Inc. (GILD)

Kategorie

Kursverlauf für Gilead Sciences, Inc. (GILD)
Höchster Schlusskurs: $148.05 am 2026-09-01

Niedrigster Schlusskurs: $0.68 am 1992-01-01
Kursverlauf der Aktie von Gilead Sciences, Inc. von 1992 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 7.70%
2025 32.61%
2024 15.91%
2023 -8.13%
2022 21.80%
2021 20.36%
2020 -10.67%
2019 1.05%
2018 -11.26%
2017 0.81%
2016 -28.48%
2015 2.18%
2014 36.94%
2013 97.77%
2012 89.46%
2011 6.00%
2010 -17.53%
2009 -5.59%
2008 2.32%
2007 41.64%
2006 23.63%
2005 49.13%
2004 22.34%
2003 58.83%
2002 9.37%
2001 62.17%
2000 85.80%
1999 26.99%
1998 -1.76%
1997 35.46%
1996 -4.73%
1995 201.99%
1994 -24.84%
1993 -22.36%
1992 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$1.15K 53.22%
US
$269.75 53.10%
US
$263.75 18.56%
US
$474.96 36.76%
CH
$146.40 79.61%
US